CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- 4 Grant or award Director acquired 5,844 shares (grant or award)
- 4 Open-market sale Director sold 10,000 shares at $17.07 ($170,707)
- 4 Grant or award Director acquired 5,844 shares (grant or award)
- 4 Shares withheld for taxes Director gave up 1,826 shares (to pay taxes)
- 4 Grant or award Director acquired 5,844 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Open-market sale Director sold 15,000 shares at $17.01 ($255,201)
- 4 Open-market sale President and General Counsel sold 11,482 shares at an average $16.92 ($194,300)
- 4 Open-market sale CFO, SVP & Treasurer sold 4,297 shares at $16.93 ($72,731)
- 4 Option exercise CEO & Chief Scientific Officer acquired 647,343 shares (option exercise)
- 4 Open-market sale Director sold 7,500 shares at $15.43 ($115,725)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- CT ORDER Other Confidential Order
- 4 Shares withheld for taxes CFO, SVP & Treasurer gave up 1,384 shares (to pay taxes)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes EVP, QA & Regulatory Affairs gave up 754 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Production Center gave up 568 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, QA & Regulatory Affairs gave up 614 shares (to pay taxes)
Page 37 of 48 · 958 filings